Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Kylian Mbappé ended his partnership with Nike (NKE) to join On (ONON) in a cash-and-equity deal, marking On's first major soccer star. Nike chose not to renew Mbappé's contract. On aims to leverage Mbappé's global profile to expand into soccer, while Nike retains other major soccer agreements. Both companies' shares showed minimal movement post-announcement.

Bank of America analyst Lorraine Hutchinson downgraded Nike (NKE) to underperform, setting a $30 price target, 15% below current levels. She cites prolonged revenue weakness, Greater China sales decline, and wholesale inventory risks. Nike's stock is down 45% year-to-date. Hutchinson also lowered EPS estimates for 2027 and 2028, raising concerns about dividend durability with a 107% payout ratio projected for 2027.

Synopsys Inc. (SNPS) rose after HSBC upgraded it to Buy with a $700 target, citing AI-driven growth. HSBC expects Synopsys to shift from moderate to high-growth, with EPS of $20.01 for 2027. Other analysts also raised targets, following strong Q3 results and raised guidance. Synopsys is pivoting to royalty-based revenue and AI integration in semiconductor design.

Synopsys shares rose following an upgrade from HSBC. The company's stock is up 0.47% today and 10.83% year-to-date. HSBC's upgrade was based on a weighted average of ratings including valuation, EPS revisions, and visibility.

HSBC upgraded Synopsys to Buy and set a $700 price target, citing a shift to royalties and AI-driven demand. The target is 60% above current levels and highest on Wall Street. Synopsys reported strong Q3 earnings and raised its full-year outlook.

Synopsys (SNPS) stock rose 5% then dropped 4% after Q3 earnings beat expectations, with 42.5% sales growth and 89% GAAP earnings increase. CEO Sassine Ghazi cited AI chip complexity driving demand. Analysts upgraded SNPS, with HSBC setting a $700 target based on non-GAAP earnings.